◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
BEAM
BEAM
(BEAM)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
Insider Monkey
·
vor 3 Std.
Prime Medicine (PRME) Reaches Positive Resolution to Arbitration with Beam Therapeutics
24/7 Wall St.
·
vor 4 Tagen
Kyverna Therapeutics Sinks 13%: Here’s Why
Simply Wall St.
·
vor 5 Tagen
Beam Therapeutics (BEAM) Faces New AATD Rival PM647 Ruling What Does It Signal Strategically?
Zacks
·
vor 5 Tagen
NTLA Surges 38% in a Month: Should You Buy, Sell or Hold the Stock?
Investor's Business Daily
·
vor 6 Tagen
Gene Editors, Including Powerhouse Beam Therapeutics, Diverge On Legal Battle
MT Newswires
·
vor 6 Tagen
Update: Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration; Shares Rise
Frag BlackSpecter AI über BEAM
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist BEAM kaufenswert?
BEAM Earnings Analyse
BEAM Bewertung
AI Chat öffnen →